US Stock MarketDetailed Quotes
SNY Sanofi
- 50.975
- -1.875-3.55%
Trading Nov 6 10:16 ET
127.80BMarket Cap25.98P/E (TTM)
51.510High50.845Low672.49KVolume51.470Open52.850Pre Close34.43MTurnover0.03%Turnover Ratio21.69P/E (Static)2.51BShares58.97052wk High1.61P/B112.43BFloat Cap43.29552wk Low2.10Dividend TTM2.21BShs Float58.970Historical High4.11%Div YieldTTM1.26%Amplitude8.844Historical Low51.200Avg Price1Lot Size
About Sanofi Company
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Company Profile
SymbolSNY
Company NameSanofi
Founded1994
CEOMr. Paul Hudson
MarketNASDAQ
Employees87994
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends12-31
Address46, avenue de la Grande Armée
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75017
Phone33-1-53-77-40-00
Websitehttp://www.sanofi.com
Company Executives
- Name
- Position
- Salary
- Paul Hudson
- Director and Chief Executive Officer
- --
- Jean-Baptiste Chasseloup De Chatillon
- Executive Vice President and Chief Financial Officer
- --
- Natalie Bickford
- Executive Vice President and Chief People Officer
- --
- Emmanuel Frenehard
- Executive Vice President and Chief Digital Officer
- --
- Julie Van Ongevalle
- Executive Vice President, Consumer Healthcare
- --
- Madeleine Roach
- Executive Vice President, Business Operations
- --
- Brendan O'Callaghan
- Executive Vice President, Global Manufacturing & Supply
- --
- Houman Ashrafian
- Executive Vice President and Head of Research and Development
- --
- Olivier Charmeil
- Executive Vice President, General Medicines
- --
- Brian Foard
- Executive Vice President, Specialty Care
- --
- Thomas Triomphe
- Executive Vice President, Vaccines
- --
- Roy Papatheodorou
- Executive Vice President and General Counsel
- --
- Frederic Oudea
- Chairman of the Board
- --
- Wolfgang Laux
- Director
- --
- Barbara Lavernos
- Director
- --
- Yann Tran
- Director
- --
- Christophe Babule
- Director
- --
- Rachel Duan
- Independent Director
- --
- Thomas Sudhof
- Independent Director
- --
- Dr. Antoine Yver, M.D.,M.Sc.
- Independent Director
- --
- Patrick Kron
- Independent Director
- --
- Lise Kingo
- Independent Director
- --
- Emile Voest
- Independent Director
- --
- Fabienne Lecorvaisier
- Independent Director
- --
- Diane Souza
- Independent Director
- --
- Carole Ferrand
- Independent Director
- --
- Gilles Schnepp
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
